etoposide has been researched along with vescalagin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auzanneau, C; De Giorgi, F; Deffieux, D; Elkaoukabi-Chaibi, A; Ichas, F; Jacquet, R; Montaudon, D; Pourquier, P; Pouységu, L; Puyo, S; Quideau, S | 1 |
1 other study(ies) available for etoposide and vescalagin
Article | Year |
---|---|
The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Catalysis; Cell Proliferation; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Kinetoplast; Down-Regulation; Etoposide; Humans; Hydrolyzable Tannins; Oxidation-Reduction; Poly-ADP-Ribose Binding Proteins; Protein Isoforms; Tumor Cells, Cultured | 2012 |